Michael Tomsicek

Mr. Tomsicek is CFO of Crispr Therapeutics and brings over 20 years of corporate and financial leadership experience to Milestone. Prior to joining CRISPR, he served as the Chief Financial Officer of Abiomed, a leading medical device company developing and commercializing products to aid in circulatory support.

Seth Fischer

Mr. Fischer joined the Milestone Pharmaceuticals Board of Directors in March 2023. He brings to the Board nearly 40 years of experience serving in key leadership positions in the pharmaceutical and medical device industry.